ProText's High-Stakes Pivot: Biotech Firm Eyes Wall Street with Blockchain

FORT LAUDERDALE, Fla. – March 13, 2026 – ProText Mobility Inc. (OTC: TXTM), a biotech firm rooted in botanical formulations, is embarking on an audacious transformation, aiming to merge its scientific research with the burgeoning world of blockchain finance. In a detailed strategic update, the company has laid out a multi-pronged plan to tokenize its assets, secure an uplisting to a major stock exchange, and redefine its valuation, signaling a high-stakes pivot from the OTC markets to the mainstream.

The company's ambitious roadmap hinges on a unique synergy: leveraging its proprietary biotech processes to create valuable assets, then converting those assets into digital tokens to unlock liquidity and fuel growth. This strategy is underpinned by a series of bold claims regarding financial discipline and a clear push towards greater transparency as it courts institutional investors.

A Dual Identity: From Botanical APIs to Digital Assets

At its core, ProText Mobility focuses on developing highly bioavailable botanical formulations, particularly from Genus Cannabis Sativa and other medicinal plants. The company touts its proprietary "kettle tech" and nanotechnology as key differentiators, claiming these processes can significantly increase the bioavailability of Active Pharmaceutical Ingredients (APIs). This technology, according to company statements, allows it to convert seed inventory into valuable APIs at scale.

The novelty in ProText's strategy lies in what happens next. The company plans to tokenize these APIs, treating them as Real-World Assets (RWAs) on the blockchain. This move taps into a rapidly expanding corner of the financial technology world. The market for tokenized RWAs has exploded, growing nearly fourfold in the past year to surpass $25 billion, as major financial institutions like BlackRock and Fidelity explore the space. By tokenizing assets like patents or, in ProText's case, pharmaceutical ingredients, companies can create fractional ownership, enhance liquidity, and potentially accelerate funding cycles outside of traditional venture capital.

ProText's approach aims to place it at the intersection of this trend, using its RWA tokenization platform to enable "interchangeability between fiat and digital assets." The recent Letter of Intent with TruLeaf is presented as a cornerstone of this plan. ProText states that TruLeaf's nanotechnology will complement its own "kettle tech" to increase API bioavailability and reduce production costs, with the resulting materials being booked as valuable RWAs on the company's balance sheet under international accounting standards.

The Path to a Major Exchange

A central pillar of ProText's strategy is its aggressive pursuit of an uplisting from the OTC market to a major national exchange like the NYSE or NASDAQ. Such a move would dramatically increase the company's visibility, credibility, and access to a broader pool of institutional capital. However, the path is rigorous and demanding.

ProText acknowledges these hurdles and has outlined several key initiatives to meet the stringent requirements. The company is in the process of completing IFRS-compliant audited financials, a critical step for any firm with global ambitions. Adherence to International Financial Reporting Standards is a prerequisite for many major exchanges and institutional investors.

Furthermore, ProText announced a preliminary engagement with Deloitte for an independent valuation of the company. In its press release, the company stated this valuation will be a "critical step in proper price discovery" and aims to demonstrate that the current stock price undervalues its intrinsic worth, which it argues includes its proprietary technology and the future value unlocked by IFRS accounting. To bolster its case and improve transparency, the company is also moving toward voluntary EDGAR reporting with the SEC and is launching a new high-tech corporate website with an integrated investor relations suite for real-time communication.

A Foundation of Financial Discipline?

To support its ambitious growth narrative, ProText emphasizes a history of extreme financial discipline. The company has repeatedly stated that it has paid no salaries to executives since its inception and has never performed a reverse stock split, moves it claims protect shareholders from dilution and unnecessary overhead. The president and chairman are also highlighted as having only ever purchased stock, with no sales, a move intended to signal deep-seated confidence in the company's future.

The company's recent press releases also claim a "zero debt" status. While this points to a strong current financial position, a review of historical filings provides a more nuanced picture. Financial statements for a prior entity, Protext Mobility, Inc. (aka Protext Pharma, Inc.), dated March 31, 2022, noted the existence of convertible notes and other payables. At that time, auditors had raised "substantial doubt about the Company's ability to continue as a going concern" due to a history of net losses and minimal revenue. This history underscores the transformative nature of the company's current strategy and places significant weight on the forthcoming IFRS-audited financials to validate its current claims of a robust, debt-free balance sheet.

Global Reach and Digital Wallets

ProText’s strategy extends beyond domestic markets, with a clear focus on global expansion and leveraging international financial systems. The company has announced "strategic liquidity arrangements" for its common stock via custodial wallets with a consortium of major financial institutions, including BNY Mellon, Standard Bank, Absa, and Melville Douglas.

This arrangement aims to use the company's stock to expand its capital base and execute its strategic goals. The involvement of BNY Mellon is particularly noteworthy, as the banking giant launched its own digital asset custody platform in 2022, signaling a commitment from traditional finance to bridge the gap with digital assets. While the specific nature of these custodial arrangements for an OTC stock is novel, it aligns with ProText's narrative of blending traditional securities with blockchain-based infrastructure.

The company also points to a "custodial wallet pilot program" designed to support foreign direct trade and the influx of foreign equities. This initiative, coupled with what ProText calls favorable "foreign exchange tailwinds" from a weakening USD against the South African Rand (ZAR), is positioned to potentially boost both revenue and profit, further strengthening its financial position as it pursues its multifaceted and ambitious global strategy.